Skip to main content
Caplight Logo









Curadev Pharma

Curadev Pharma

Private
NoidaHealthcare & Life Scienceshttps://www.curadev.in/

Last Round

Grant

Apr 1, 2016

Total Funding Raised

$2.2M

Company Overview

Curadev Pharma is a biotechnology company that discovers and develops novel small molecule therapeutics for intractable diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

small molecule drug discoverypreclinical drug developmentbiotechdrug discovery servicesoncology therapeuticsimmunology researchcontract research organizationCROmedicinal chemistrySTING agonistIDO inhibitorTDO inhibitorbiopharmadrug licensingwet-lab discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curadev Pharma Comparables

Compare Curadev Pharma with similar companies based on industry and business-model similarity.

Curadev Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nimbus Therapeutics
82%
TheraIndx Lifesciences
78%
IFM Therapeutics
77%

Curadev Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2016
VC RoundAug 1, 2013
AngelMar 31, 2011
DebtMar 1, 2011

Curadev Pharma Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2025

    Monthly visitors increased 77% MoM.

  • Jun 1, 2025

    Monthly visitors increased 521% MoM.

Curadev Pharma Filings

Explore SEC and related filing metadata, where available.

Curadev Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curadev Pharma's valuation, stock price, and market status.

Is Curadev Pharma a public or private company?

Curadev Pharma is a private company.

What is the current stock price of Curadev Pharma?

Curadev Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Curadev Pharma worth (valuation)?

Valuation information for Curadev Pharma is not publicly available.

Can I buy Curadev Pharma stock?

Curadev Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curadev Pharma's last funding round?

Curadev Pharma's most recent funding round was Grant on April 1, 2016.

Who are the main investors in Curadev Pharma?

Key investors in Curadev Pharma include Department of Biotechnology.

Will Curadev Pharma IPO soon?

No public IPO plans have been announced for Curadev Pharma.

How can I track Curadev Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curadev Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNoida
Employee Range40
Year Founded2010
Last FundingApr 1, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?